 |
Minimalna wpłata $50 Ekskluzywna promocja |
Nasz wynik |
0% prowizja |
Are you looking to buy Lineage Cell Therapeutics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:LCTX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Lineage Cell Therapeutics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also develops Renevia, a facial aesthetics product that is in clinical trial for the treatment of HIV-associated facial lipoatrophy; HyStem, a biomaterial used for cell replacement and retention; and Premvia, a Hystem Hydrogel product, as well as develops bone grafting products for the orthopedic diseases and injuries. In addition, the company offers various therapeutic products for the treatment of oncology, neurological diseases and disorders, blood and vascular system diseases and disorders, and blood plasma volume expansion, as well as undertakes various research programs for vision restoration and Demyelination. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Średnia wielkość
2.16 million shs
KAPITAŁ RYNKOWY
$416.97 million
Giełda Papierów Wartościowych
NYSEAMERICAN
Proszę kupić te akcje!
|
NAZWA
|
TICKER
|
PRZEMYSŁ
|
SEKTOR
|
VOLUME
|
KUP TERAZ TĘ AKCJĘ
|
|---|---|---|---|---|---|
|
AMEX:LCTX
|
Produkty biologiczne, z wyjątkiem diagnostycznych
|
Medyczny
|
39,559 shs
|
Below is a quick guide on how to buy AMEX:LCTX stocks safe, fast and around the world in less than five minutes.
Krok 1: Otworzyć rachunek w eToro – eToro is the best broker to buy Lineage Cell Therapeutics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Krok 2: Załadować Państwa ID - Zgodnie z przepisami KYC eToro poprosi Państwa o przesłanie kopii paszportu lub prawa jazdy.
Krok 3: Wpłata środków - Proszę wpłacić trochę pieniędzy na swoje nowo utworzone konto eToro. Mogą Państwo wybrać pomiędzy przelewem bankowym, e-wallet lub kartą debetową/kredytową lub Paypal.
Krok 4: Buy Lineage Cell Therapeutics – Search for “”AMEX:LCTX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Lineage Cell Therapeutics stocks with 0% commission!.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
5 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Lineage Cell Therapeutics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Lineage Cell Therapeutics stock.
Wall Street analysts have given Lineage Cell Therapeutics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Lineage Cell Therapeutics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
2 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
3 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:LCTX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Lineage Cell Therapeutics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Lineage Cell Therapeutics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Ponieważ eToro jest platformą regulowaną, musi Pan wypełnić proces KYC, jest to standardowa procedura i zajmuje tylko kilka minut. Musi Pan przedstawić dowód tożsamości ze zdjęciem (paszport, prawo jazdy) oraz dowód adresu (rachunek za media, wyciąg z banku).
Po zarejestrowaniu się i zweryfikowaniu konta, należy wpłacić środki. eToro akceptuje karty kredytowe/debetowe, przelewy bankowe, a także e-wallety. Tak więc niezależnie od Państwa preferencji znajdzie się coś dla Państwa.
Now that you’ve funded your eToro account, just type “AMEX:LCTX stocks" w pasku wyszukiwania na górze ekranu i nacisnąć "handel".
All that’s left is to buy some AMEX:LCTX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:LCTX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Lineage Cell Therapeutics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Lineage Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Lineage Cell Therapeutics.
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) released its quarterly earnings results on Wednesday, November, 4th. The company reported ($0.05) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.05). The company earned $0.57 million during the quarter, compared to the consensus estimate of $0.65 million. Lineage Cell Therapeutics had a negative net margin of 1,001.59% and a negative trailing twelve-month return on equity of 26.07%.
View Lineage Cell Therapeutics’ earnings history.
5 brokers have issued 1 year price objectives for Lineage Cell Therapeutics’ shares. Their forecasts range from $3.00 to $6.00. On average, they anticipate Lineage Cell Therapeutics’ stock price to reach $4.33 in the next year. This suggests a possible upside of 55.9% from the stock’s current price.
View analysts’ price targets for Lineage Cell Therapeutics or view top-rated stocks among Wall Street analysts.
Lineage Cell Therapeutics’ management team includes the following people:
Mr. Brian M. Culley, CEO, Pres & Director (Age 50, Pay $772.74k)
Ms. Brandi L. Roberts, Chief Financial Officer (Age 47, Pay $550.01k)
Mr. Chase C. Leavitt, Gen. Counsel & Corp. Sec. (Age 40, Pay $321.79k)
Ioana C. Hone, Dyrektor ds. relacji inwestorskich
Mr. James Knight, Sr. VP & Head of Corp. Devel.
Dr. François Binette M.Sc., Ph.D., Sr. VP & Global Head of R&D
Dr. Gary S. Hogge D.V.M., Dvm, Ms, Ph.D., Sr. VP of Clinical & Medical Affairs (Age 53)
Mr. William Annett, Pres & CEO of OncoCyte Corp. (Age 67)
Dr. Rami Skaliter, Chief Exec. Officer of Cell Cure Neurosciences Ltd. (Age 63)
Dr. Harold D. Waitz, VP of Regulatory Affairs & Quality Control (Age 79)
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:LCTX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Ponad 95% środków klientów jest przechowywanych w trybie offline, w zimnym magazynie, co jest kluczowe dla każdego brokera, który zarządza Państwa aktywami. Niezależnie od tego, jak bezpieczna ma być platforma, zalecamy stosowanie 2FA, aby dodać dodatkową warstwę bezpieczeństwa do Państwa konta.
eToro oferuje użytkownikom szereg funkcji, aby mogli Państwo jak najszybciej zacząć inwestować. Mają Państwo stosunkowo unikalną funkcję copy trading, która pozwala na uzyskanie pasywnego dochodu poprzez odzwierciedlanie doświadczonych traderów, co pozwala szybko zacząć zarabiać i daje lepsze zrozumienie strategii stosowanych przez profesjonalistów. Dodatkowo eToro umożliwia użytkownikom inwestowanie w zarządzane portfele, przy czym zarządzany portfel to różne podobne aktywa zgrupowane razem, co pozwala na dywersyfikację konta i zmniejsza ewentualne ryzyko. Dla tych, którzy mają już doświadczenie w handlu, mogą Państwo inwestować na rynkach poza akcjami, ponieważ eToro pozwala użytkownikom na handel ETF-ami, towarami, kryptowalutami i indeksami. Jeżeli już inwestują Państwo poza przestrzenią giełdową, może to być bardzo przydatne, ponieważ pozwala to na zarządzanie wszystkimi Państwa inwestycjami w jednym miejscu.
Some companies that are related to Lineage Cell Therapeutics include Inhibrx (INBX), Adverum Biotechnologies (ADVM), Krystal Biotech (KRYS), Cortexyme (CRTX), Coherus BioSciences (CHRS), Vaxcyte (PCVX), Taysha Gene Therapies (TSHA), Mesoblast (MESO), Cellectis (CLLS), Rubius Therapeutics (RUBY), Black Diamond Therapeutics (BDTX), Sutro Biopharma (STRO), Passage Bio (PASG), Agenus (AGEN) and TCR2 Therapeutics (TCRR).
View all of LCTX’s competitors.
Based on aggregate information from Reportlab, some companies that other Lineage Cell Therapeutics investors own include Matinas BioPharma (MTNB), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), ADMA Biologics (ADMA), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI), Cannabics Pharmaceuticals (CNBX), Enerplus (ERF), KushCo (KSHB) and Zosano Pharma (ZSAN).
CFD są złożonymi instrumentami i wiążą się z wysokim ryzykiem szybkiej utraty pieniędzy z powodu dźwigni finansowej. 68% kont inwestorów detalicznych traci pieniądze przy handlu CFD u tego dostawcy. Powinni Państwo rozważyć, czy rozumieją Państwo, jak działają kontrakty CFD i czy mogą sobie Państwo pozwolić na wysokie ryzyko utraty pieniędzy.
Lineage Cell Therapeutics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “LCTX.”
Lineage Cell Therapeutics’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include Defender Capital LLC. (3.16%), BlackRock Inc. (1.07%) and Wealth Architects LLC (0.01%). Company insiders that own Lineage Cell Therapeutics stock include Brian M Culley, Broadwood Partners, LP and Chase C Leavitt.
View institutional ownership trends for Lineage Cell Therapeutics.
LCTX stock was sold by a variety of institutional investors in the last quarter, including Defender Capital LLC..
View insider buying and selling activity for Lineage Cell Therapeutics or view top insider-selling stocks.
LCTX stock was bought by a variety of institutional investors in the last quarter, including Wealth Architects LLC, and BlackRock Inc.. Company insiders that have bought Lineage Cell Therapeutics stock in the last two years include Brian M Culley, Broadwood Partners, LP, and Chase C Leavitt.
View insider buying and selling activity for Lineage Cell Therapeutics or or view top insider-buying stocks.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
Shares of LCTX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, Przegląd DEGiro, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review i wiele innych. Proszę przeczytać jedną z recenzji, aby dowiedzieć się wszystkiego o brokerze i zacząć kupować akcje już teraz.
One share of LCTX stock can currently be purchased for approximately $2.78.
Lineage Cell Therapeutics has a market capitalization of $416.97 million and generates $3.52 million in revenue each year. The company earns $-11,710,000.00 in net income (profit) each year or $0.14 on an earnings per share basis.
Lineage Cell Therapeutics employs 50 workers across the globe.
The official website for Lineage Cell Therapeutics is www.lineagecell.com.
Lineage Cell Therapeutics is headquartered at 2173 SALK AVENUE SUITE 200, CARLSBAD CA, 92008.
Na Reportlab.org chcemy się upewnić, że mają Państwo wszystkie najbardziej istotne informacje na temat kupno akcji. Przynosimy Państwu najlepsze przewodniki po giełdzie z osobistymi opiniami, informacjami uzupełniającymi, opiniami o platformach, how to's i więcej. Chcą Państwo uzyskać inne informacje? Proszę zajrzeć na stronę Akcje OTC, Akcje NASDAQ, Akcje na NYSE, Akcje LON, Akcje FRA, Akcje ETR, Zapasy EPA, Akcje TSX lub Akcje Amex. Szukam bardziej szczegółowych informacji, takich jak 5g zapasy, akcje biotechnologiczne, akcje złota i inne informacje z naszego Reportlab.
How can you buy Lineage Cell Therapeutics stock on the internet?
You can easily buy Lineage Cell Therapeutics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Inną opcją jest skorzystanie z usług regulowanego brokera, jak np. IC Markets lub Interactive Brokers. You can an account with these brokers and start buying or trading AMEX:LCTX stocks in a safe and complete environment to trade in.
Where to buy Lineage Cell Therapeutics stock?
You will first want to find a licensed broker that supports AMEX:LCTX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:LCTX stocks in a safe and complete environment.
Is AMEX:LCTX stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:LCTX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Lineage Cell Therapeutics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:LCTX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Lineage Cell Therapeutics stock.
How do you trade Lineage Cell Therapeutics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Lineage Cell Therapeutics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:LCTX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Lineage Cell Therapeutics stock?
To sell your AMEX:LCTX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Lineage Cell Therapeutics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:LCTX stock.
Stephen wie wiele o produktach finansowych, a w szczególności pasjonuje się rynkami giełdowymi i ich uczestnikami. Mamy nadzieję, że przedstawione informacje będą dla Państwa pomocne. Coś nie jest całkiem jasne? Proszę zostawić swoje pytania lub komentarze na dole strony.
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ |
Newsletter
Najnowsze wiadomości
| |
Nasz wynik |
0% prowizja |
Dane o akcjach i kryptowalutach w czasie rzeczywistym
Powiadomienia, Porady & Nowości
Best Stocks & Crypto Guides
Recenzje brokerów i giełd online
Reportlab Finance jest stroną czysto informacyjną i w żadnym wypadku nie oznacza doradztwa inwestycyjnego. Wszystkie inwestycje niosą ze sobą ryzyko i mogą Państwo stracić wszystkie swoje inwestycje. Proszę nie inwestować pieniędzy, na których utratę nie mogą sobie Państwo pozwolić.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
Zjednoczone Królestwo
Copyright © 2022 Reportlab.Finance | Wszystkie prawa zastrzeżone.
